LRG1 and familial pancreatic carcinoma: Several biomarkers consisting of apolipoprotein A-IV, monocyte differentiation antigen CD14, and LRG1 demonstrated their influences on the differentiation between diabetes and early pancreatic cancer (Peng et al., 2020).